menu
    • menu

    Company profile for Cantargia AB

    NEW Drugs in Dev: 4
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cantargia is a Swedish biotechnology company that specialises in the development of pharmaceuticals for various types of cancer diseases and autoimmune/inflammatory diseases. Our development programme includes the product candidate CAN04, which is currently in phase IIa clinical studies, as well as our discovery project CANxx. The company is listed on OMX Stockholm’s Main List (Small Cap). Cantargia AB was formed in 2009-201...
    Cantargia is a Swedish biotechnology company that specialises in the development of pharmaceuticals for various types of cancer diseases and autoimmune/inflammatory diseases. Our development programme includes the product candidate CAN04, which is currently in phase IIa clinical studies, as well as our discovery project CANxx. The company is listed on OMX Stockholm’s Main List (Small Cap). Cantargia AB was formed in 2009-2010 with the aim of refining a discovery by Professor Thoas Fioretos and Doctor Marcus Järås of Lund University.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cantargia ABSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Medicon Village, Scheelevägen 2 SE-223 81 Lund
    Telephone
    Telephone
    +46(0)46 2756260
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cantargia.com/en/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/cantargia-ab
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/cantargia?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASCO GU

    ASCO GU

    Not Confirmed

    envelop Contact Supplier

    ASCO GU

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cantargia Joins TD Cowen Healthcare Conference
    Cantargia Joins TD Cowen Healthcare Conference

    23 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-23/cantargia-to-participate-in-td-cowens-annual-healthcare-conference

    PHARMIWEB
    23 Feb 2026
    Share Share
    Cantargia To Present 2025 Annual Results
    Cantargia To Present 2025 Annual Results

    06 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-06/invitation-to-the-presentation-of-cantargias-annual-results-for-2025

    PHARMIWEB
    06 Feb 2026
    Share Share
    Cantargia Doses First Patient in U.S. Colorectal Cancer Trial
    Cantargia Doses First Patient in U.S. Colorectal Cancer Trial

    23 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-23/cantargia-reports-first-patient-dosed-in-new-us-investigator-initiated-colorectal-cancer-study

    PHARMIWEB
    23 Jan 2026
    Share Share
    Cantargia Provides Update On Overall Survival Data From TRIFOUR
    Cantargia Provides Update On Overall Survival Data From TRIFOUR

    05 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-05/cantargia-provides-update-on-overall-survival-data-from-trifour

    PHARMIWEB
    05 Dec 2025
    Share Share
    Cantargia Publishes Interim Report for January to September 2025
    Cantargia Publishes Interim Report for January to September 2025

    19 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-19/cantargia-publishes-interim-report-for-january-to-september-2025

    PHARMIWEB
    19 Nov 2025
    Share Share
    Cantargia Presents Nomination Committee Ahead Of 2026 AGM
    Cantargia Presents Nomination Committee Ahead Of 2026 AGM

    12 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-12/cantargia-presents-nomination-committee-ahead-of-2026-agm

    PHARMIWEB
    12 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search